Summary

The global IgG2b Antibody market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
IgG2b Antibody is a subclass of the IgG antibody, one of the major classes of antibodies produced by the immune system. IgG2b antibodies are involved in immune responses by recognizing and neutralizing foreign substances such as bacteria and viruses. This subclass of IgG antibodies is known for its ability to activate complement, a part of the immune system that helps to destroy pathogens. IgG2b antibodies are commonly used in research and diagnostic applications to study immune responses and detect the presence of certain diseases.
The industry trend for IgG2b Antibody has experienced growth due to its importance in immunology research and diagnostics. These antibodies are essential for understanding the humoral immune response and have significant applications in the development of vaccines, therapeutic antibodies, and diagnostic tests. The potential for IgG2b Antibody in personalized medicine and precision diagnostics is expected to drive the industry trend forward. As the field of immunology continues to advance, the use of IgG2b Antibody in research and potential clinical applications is likely to remain strong.
The global IgG2b Antibody market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Bio-Rad
MyBioSource
Novus Biologicals
BosterBio
RayBiotech
Biorbyt
Bio X Cell
Abeomics
Cell Sciences
SouthernBiotech
Thermo Fisher Scientific
Miltenyi Biotec
R&D Systems
Wuhan Fine Biotech
BioLegend
LI-COR Biosciences
ichorbio
Proteintech
OriGene Technologies
Aviva Systems Biology
Antigenix America
LSBio
Tonbo Biosciences
BPS Bioscience
IBL
Merck
GeneTex
NSJ Bioreagents
Mabtech
American Research Products
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of IgG2b Antibody market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the IgG2b Antibody value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG2b Antibody Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global IgG2b Antibody Market Share by Revenue, by Region (2021-2026)
2.4 Global IgG2b Antibody Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America IgG2b Antibody Market Size and Prospective (2021-2032)
2.5.2 Europe IgG2b Antibody Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific IgG2b Antibody Market Size and Prospective (2021-2032)
2.5.4 Latin America IgG2b Antibody Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa IgG2b Antibody Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global IgG2b Antibody Historical Market Size by Type (2021-2026)
3.2 Global IgG2b Antibody Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of IgG2b Antibody
4 Breakdown Data by Application
4.1 Global IgG2b Antibody Historical Market Size by Application (2021-2026)
4.2 Global IgG2b Antibody Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in IgG2b Antibody Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top IgG2b Antibody Players by Revenue (2021-2026)
5.1.2 Global IgG2b Antibody Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by IgG2b Antibody Revenue
5.4 Global IgG2b Antibody Market Concentration Analysis
5.4.1 Global IgG2b Antibody Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by IgG2b Antibody Revenue in 2025
5.5 Global Key Players of IgG2b Antibody Head Offices and Areas Served
5.6 Global Key Players of IgG2b Antibody, Product and Application
5.7 Global Key Players of IgG2b Antibody, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America IgG2b Antibody Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America IgG2b Antibody Market Size by Type (2021-2026)
6.1.2.2 North America IgG2b Antibody Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America IgG2b Antibody Market Size by Application (2021-2026)
6.1.3.2 North America IgG2b Antibody Market Share by Application (2021-2026)
6.1.4 North America IgG2b Antibody Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe IgG2b Antibody Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe IgG2b Antibody Market Size by Type (2021-2026)
6.2.2.2 Europe IgG2b Antibody Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe IgG2b Antibody Market Size by Application (2021-2026)
6.2.3.2 Europe IgG2b Antibody Market Share by Application (2021-2026)
6.2.4 Europe IgG2b Antibody Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific IgG2b Antibody Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific IgG2b Antibody Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific IgG2b Antibody Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific IgG2b Antibody Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific IgG2b Antibody Market Share by Application (2021-2026)
6.3.4 Asia-Pacific IgG2b Antibody Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America IgG2b Antibody Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America IgG2b Antibody Market Size by Type (2021-2026)
6.4.2.2 Latin America IgG2b Antibody Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America IgG2b Antibody Market Size by Application (2021-2026)
6.4.3.2 Latin America IgG2b Antibody Market Share by Application (2021-2026)
6.4.4 Latin America IgG2b Antibody Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa IgG2b Antibody Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa IgG2b Antibody Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa IgG2b Antibody Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa IgG2b Antibody Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa IgG2b Antibody Market Share by Application (2021-2026)
6.5.4 Middle East & Africa IgG2b Antibody Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities
7 Key Player Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Company Details
7.1.2 Bio-Rad Business Overview
7.1.3 Bio-Rad IgG2b Antibody Introduction
7.1.4 Bio-Rad Revenue in IgG2b Antibody Business (2021-2026)
7.1.5 Bio-Rad Recent Development
7.2 MyBioSource
7.2.1 MyBioSource Company Details
7.2.2 MyBioSource Business Overview
7.2.3 MyBioSource IgG2b Antibody Introduction
7.2.4 MyBioSource Revenue in IgG2b Antibody Business (2021-2026)
7.2.5 MyBioSource Recent Development
7.3 Novus Biologicals
7.3.1 Novus Biologicals Company Details
7.3.2 Novus Biologicals Business Overview
7.3.3 Novus Biologicals IgG2b Antibody Introduction
7.3.4 Novus Biologicals Revenue in IgG2b Antibody Business (2021-2026)
7.3.5 Novus Biologicals Recent Development
7.4 BosterBio
7.4.1 BosterBio Company Details
7.4.2 BosterBio Business Overview
7.4.3 BosterBio IgG2b Antibody Introduction
7.4.4 BosterBio Revenue in IgG2b Antibody Business (2021-2026)
7.4.5 BosterBio Recent Development
7.5 RayBiotech
7.5.1 RayBiotech Company Details
7.5.2 RayBiotech Business Overview
7.5.3 RayBiotech IgG2b Antibody Introduction
7.5.4 RayBiotech Revenue in IgG2b Antibody Business (2021-2026)
7.5.5 RayBiotech Recent Development
7.6 Biorbyt
7.6.1 Biorbyt Company Details
7.6.2 Biorbyt Business Overview
7.6.3 Biorbyt IgG2b Antibody Introduction
7.6.4 Biorbyt Revenue in IgG2b Antibody Business (2021-2026)
7.6.5 Biorbyt Recent Development
7.7 Bio X Cell
7.7.1 Bio X Cell Company Details
7.7.2 Bio X Cell Business Overview
7.7.3 Bio X Cell IgG2b Antibody Introduction
7.7.4 Bio X Cell Revenue in IgG2b Antibody Business (2021-2026)
7.7.5 Bio X Cell Recent Development
7.8 Abeomics
7.8.1 Abeomics Company Details
7.8.2 Abeomics Business Overview
7.8.3 Abeomics IgG2b Antibody Introduction
7.8.4 Abeomics Revenue in IgG2b Antibody Business (2021-2026)
7.8.5 Abeomics Recent Development
7.9 Cell Sciences
7.9.1 Cell Sciences Company Details
7.9.2 Cell Sciences Business Overview
7.9.3 Cell Sciences IgG2b Antibody Introduction
7.9.4 Cell Sciences Revenue in IgG2b Antibody Business (2021-2026)
7.9.5 Cell Sciences Recent Development
7.10 SouthernBiotech
7.10.1 SouthernBiotech Company Details
7.10.2 SouthernBiotech Business Overview
7.10.3 SouthernBiotech IgG2b Antibody Introduction
7.10.4 SouthernBiotech Revenue in IgG2b Antibody Business (2021-2026)
7.10.5 SouthernBiotech Recent Development
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Details
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific IgG2b Antibody Introduction
7.11.4 Thermo Fisher Scientific Revenue in IgG2b Antibody Business (2021-2026)
7.11.5 Thermo Fisher Scientific Recent Development
7.12 Miltenyi Biotec
7.12.1 Miltenyi Biotec Company Details
7.12.2 Miltenyi Biotec Business Overview
7.12.3 Miltenyi Biotec IgG2b Antibody Introduction
7.12.4 Miltenyi Biotec Revenue in IgG2b Antibody Business (2021-2026)
7.12.5 Miltenyi Biotec Recent Development
7.13 R&D Systems
7.13.1 R&D Systems Company Details
7.13.2 R&D Systems Business Overview
7.13.3 R&D Systems IgG2b Antibody Introduction
7.13.4 R&D Systems Revenue in IgG2b Antibody Business (2021-2026)
7.13.5 R&D Systems Recent Development
7.14 Wuhan Fine Biotech
7.14.1 Wuhan Fine Biotech Company Details
7.14.2 Wuhan Fine Biotech Business Overview
7.14.3 Wuhan Fine Biotech IgG2b Antibody Introduction
7.14.4 Wuhan Fine Biotech Revenue in IgG2b Antibody Business (2021-2026)
7.14.5 Wuhan Fine Biotech Recent Development
7.15 BioLegend
7.15.1 BioLegend Company Details
7.15.2 BioLegend Business Overview
7.15.3 BioLegend IgG2b Antibody Introduction
7.15.4 BioLegend Revenue in IgG2b Antibody Business (2021-2026)
7.15.5 BioLegend Recent Development
7.16 LI-COR Biosciences
7.16.1 LI-COR Biosciences Company Details
7.16.2 LI-COR Biosciences Business Overview
7.16.3 LI-COR Biosciences IgG2b Antibody Introduction
7.16.4 LI-COR Biosciences Revenue in IgG2b Antibody Business (2021-2026)
7.16.5 LI-COR Biosciences Recent Development
7.17 ichorbio
7.17.1 ichorbio Company Details
7.17.2 ichorbio Business Overview
7.17.3 ichorbio IgG2b Antibody Introduction
7.17.4 ichorbio Revenue in IgG2b Antibody Business (2021-2026)
7.17.5 ichorbio Recent Development
7.18 Proteintech
7.18.1 Proteintech Company Details
7.18.2 Proteintech Business Overview
7.18.3 Proteintech IgG2b Antibody Introduction
7.18.4 Proteintech Revenue in IgG2b Antibody Business (2021-2026)
7.18.5 Proteintech Recent Development
7.19 OriGene Technologies
7.19.1 OriGene Technologies Company Details
7.19.2 OriGene Technologies Business Overview
7.19.3 OriGene Technologies IgG2b Antibody Introduction
7.19.4 OriGene Technologies Revenue in IgG2b Antibody Business (2021-2026)
7.19.5 OriGene Technologies Recent Development
7.20 Aviva Systems Biology
7.20.1 Aviva Systems Biology Company Details
7.20.2 Aviva Systems Biology Business Overview
7.20.3 Aviva Systems Biology IgG2b Antibody Introduction
7.20.4 Aviva Systems Biology Revenue in IgG2b Antibody Business (2021-2026)
7.20.5 Aviva Systems Biology Recent Development
7.21 Antigenix America
7.21.1 Antigenix America Company Details
7.21.2 Antigenix America Business Overview
7.21.3 Antigenix America IgG2b Antibody Introduction
7.21.4 Antigenix America Revenue in IgG2b Antibody Business (2021-2026)
7.21.5 Antigenix America Recent Development
7.22 LSBio
7.22.1 LSBio Company Details
7.22.2 LSBio Business Overview
7.22.3 LSBio IgG2b Antibody Introduction
7.22.4 LSBio Revenue in IgG2b Antibody Business (2021-2026)
7.22.5 LSBio Recent Development
7.23 Tonbo Biosciences
7.23.1 Tonbo Biosciences Company Details
7.23.2 Tonbo Biosciences Business Overview
7.23.3 Tonbo Biosciences IgG2b Antibody Introduction
7.23.4 Tonbo Biosciences Revenue in IgG2b Antibody Business (2021-2026)
7.23.5 Tonbo Biosciences Recent Development
7.24 BPS Bioscience
7.24.1 BPS Bioscience Company Details
7.24.2 BPS Bioscience Business Overview
7.24.3 BPS Bioscience IgG2b Antibody Introduction
7.24.4 BPS Bioscience Revenue in IgG2b Antibody Business (2021-2026)
7.24.5 BPS Bioscience Recent Development
7.25 IBL
7.25.1 IBL Company Details
7.25.2 IBL Business Overview
7.25.3 IBL IgG2b Antibody Introduction
7.25.4 IBL Revenue in IgG2b Antibody Business (2021-2026)
7.25.5 IBL Recent Development
7.26 Merck
7.26.1 Merck Company Details
7.26.2 Merck Business Overview
7.26.3 Merck IgG2b Antibody Introduction
7.26.4 Merck Revenue in IgG2b Antibody Business (2021-2026)
7.26.5 Merck Recent Development
7.27 GeneTex
7.27.1 GeneTex Company Details
7.27.2 GeneTex Business Overview
7.27.3 GeneTex IgG2b Antibody Introduction
7.27.4 GeneTex Revenue in IgG2b Antibody Business (2021-2026)
7.27.5 GeneTex Recent Development
7.28 NSJ Bioreagents
7.28.1 NSJ Bioreagents Company Details
7.28.2 NSJ Bioreagents Business Overview
7.28.3 NSJ Bioreagents IgG2b Antibody Introduction
7.28.4 NSJ Bioreagents Revenue in IgG2b Antibody Business (2021-2026)
7.28.5 NSJ Bioreagents Recent Development
7.29 Mabtech
7.29.1 Mabtech Company Details
7.29.2 Mabtech Business Overview
7.29.3 Mabtech IgG2b Antibody Introduction
7.29.4 Mabtech Revenue in IgG2b Antibody Business (2021-2026)
7.29.5 Mabtech Recent Development
7.30 American Research Products
7.30.1 American Research Products Company Details
7.30.2 American Research Products Business Overview
7.30.3 American Research Products IgG2b Antibody Introduction
7.30.4 American Research Products Revenue in IgG2b Antibody Business (2021-2026)
7.30.5 American Research Products Recent Development
8 IgG2b Antibody Market Dynamics
8.1 IgG2b Antibody Industry Trends
8.2 IgG2b Antibody Market Drivers
8.3 IgG2b Antibody Market Challenges
8.4 IgG2b Antibody Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global IgG2b Antibody Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global IgG2b Antibody Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market IgG2b Antibody Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global IgG2b Antibody Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global IgG2b Antibody Revenue Share by Region (2021-2026)
Table 6. Global IgG2b Antibody Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global IgG2b Antibody Revenue Share Forecast by Region (2027-2032)
Table 8. Global IgG2b Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global IgG2b Antibody Market Share by Revenue, by Type (2021-2026)
Table 10. Global IgG2b Antibody Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global IgG2b Antibody Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global IgG2b Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global IgG2b Antibody Market Share by Revenue, by Application (2021-2026)
Table 15. Global IgG2b Antibody Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global IgG2b Antibody Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in IgG2b Antibody Applications
Table 18. Global IgG2b Antibody Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global IgG2b Antibody Market Share by Players (2021-2026)
Table 20. Global Top IgG2b Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG2b Antibody as of 2025)
Table 21. Ranking of Global Top IgG2b Antibody Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by IgG2b Antibody Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of IgG2b Antibody, Headquarters and Area Served
Table 24. Global Key Players of IgG2b Antibody, Product and Application
Table 25. Global Key Players of IgG2b Antibody, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America IgG2b Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America IgG2b Antibody Market Share by Revenue, by Company (2021-2026)
Table 29. North America IgG2b Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America IgG2b Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe IgG2b Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe IgG2b Antibody Market Share by Revenue, by Company (2021-2026)
Table 33. Europe IgG2b Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe IgG2b Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific IgG2b Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific IgG2b Antibody Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific IgG2b Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific IgG2b Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America IgG2b Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America IgG2b Antibody Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America IgG2b Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America IgG2b Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa IgG2b Antibody Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa IgG2b Antibody Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa IgG2b Antibody Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa IgG2b Antibody Market Size by Application (2021-2026) & (US$ Million)
Table 47. Bio-Rad Company Details
Table 48. Bio-Rad Business Overview
Table 49. Bio-Rad IgG2b Antibody Product
Table 50. Bio-Rad Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 51. Bio-Rad Recent Development
Table 52. MyBioSource Company Details
Table 53. MyBioSource Business Overview
Table 54. MyBioSource IgG2b Antibody Product
Table 55. MyBioSource Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 56. MyBioSource Recent Development
Table 57. Novus Biologicals Company Details
Table 58. Novus Biologicals Business Overview
Table 59. Novus Biologicals IgG2b Antibody Product
Table 60. Novus Biologicals Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 61. Novus Biologicals Recent Development
Table 62. BosterBio Company Details
Table 63. BosterBio Business Overview
Table 64. BosterBio IgG2b Antibody Product
Table 65. BosterBio Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 66. BosterBio Recent Development
Table 67. RayBiotech Company Details
Table 68. RayBiotech Business Overview
Table 69. RayBiotech IgG2b Antibody Product
Table 70. RayBiotech Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 71. RayBiotech Recent Development
Table 72. Biorbyt Company Details
Table 73. Biorbyt Business Overview
Table 74. Biorbyt IgG2b Antibody Product
Table 75. Biorbyt Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 76. Biorbyt Recent Development
Table 77. Bio X Cell Company Details
Table 78. Bio X Cell Business Overview
Table 79. Bio X Cell IgG2b Antibody Product
Table 80. Bio X Cell Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 81. Bio X Cell Recent Development
Table 82. Abeomics Company Details
Table 83. Abeomics Business Overview
Table 84. Abeomics IgG2b Antibody Product
Table 85. Abeomics Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 86. Abeomics Recent Development
Table 87. Cell Sciences Company Details
Table 88. Cell Sciences Business Overview
Table 89. Cell Sciences IgG2b Antibody Product
Table 90. Cell Sciences Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 91. Cell Sciences Recent Development
Table 92. SouthernBiotech Company Details
Table 93. SouthernBiotech Business Overview
Table 94. SouthernBiotech IgG2b Antibody Product
Table 95. SouthernBiotech Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 96. SouthernBiotech Recent Development
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific IgG2b Antibody Product
Table 100. Thermo Fisher Scientific Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 101. Thermo Fisher Scientific Recent Development
Table 102. Miltenyi Biotec Company Details
Table 103. Miltenyi Biotec Business Overview
Table 104. Miltenyi Biotec IgG2b Antibody Product
Table 105. Miltenyi Biotec Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 106. Miltenyi Biotec Recent Development
Table 107. R&D Systems Company Details
Table 108. R&D Systems Business Overview
Table 109. R&D Systems IgG2b Antibody Product
Table 110. R&D Systems Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 111. R&D Systems Recent Development
Table 112. Wuhan Fine Biotech Company Details
Table 113. Wuhan Fine Biotech Business Overview
Table 114. Wuhan Fine Biotech IgG2b Antibody Product
Table 115. Wuhan Fine Biotech Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 116. Wuhan Fine Biotech Recent Development
Table 117. BioLegend Company Details
Table 118. BioLegend Business Overview
Table 119. BioLegend IgG2b Antibody Product
Table 120. BioLegend Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 121. BioLegend Recent Development
Table 122. LI-COR Biosciences Company Details
Table 123. LI-COR Biosciences Business Overview
Table 124. LI-COR Biosciences IgG2b Antibody Product
Table 125. LI-COR Biosciences Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 126. LI-COR Biosciences Recent Development
Table 127. ichorbio Company Details
Table 128. ichorbio Business Overview
Table 129. ichorbio IgG2b Antibody Product
Table 130. ichorbio Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 131. ichorbio Recent Development
Table 132. Proteintech Company Details
Table 133. Proteintech Business Overview
Table 134. Proteintech IgG2b Antibody Product
Table 135. Proteintech Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 136. Proteintech Recent Development
Table 137. OriGene Technologies Company Details
Table 138. OriGene Technologies Business Overview
Table 139. OriGene Technologies IgG2b Antibody Product
Table 140. OriGene Technologies Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 141. OriGene Technologies Recent Development
Table 142. Aviva Systems Biology Company Details
Table 143. Aviva Systems Biology Business Overview
Table 144. Aviva Systems Biology IgG2b Antibody Product
Table 145. Aviva Systems Biology Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 146. Aviva Systems Biology Recent Development
Table 147. Antigenix America Company Details
Table 148. Antigenix America Business Overview
Table 149. Antigenix America IgG2b Antibody Product
Table 150. Antigenix America Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 151. Antigenix America Recent Development
Table 152. LSBio Company Details
Table 153. LSBio Business Overview
Table 154. LSBio IgG2b Antibody Product
Table 155. LSBio Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 156. LSBio Recent Development
Table 157. Tonbo Biosciences Company Details
Table 158. Tonbo Biosciences Business Overview
Table 159. Tonbo Biosciences IgG2b Antibody Product
Table 160. Tonbo Biosciences Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 161. Tonbo Biosciences Recent Development
Table 162. BPS Bioscience Company Details
Table 163. BPS Bioscience Business Overview
Table 164. BPS Bioscience IgG2b Antibody Product
Table 165. BPS Bioscience Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 166. BPS Bioscience Recent Development
Table 167. IBL Company Details
Table 168. IBL Business Overview
Table 169. IBL IgG2b Antibody Product
Table 170. IBL Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 171. IBL Recent Development
Table 172. Merck Company Details
Table 173. Merck Business Overview
Table 174. Merck IgG2b Antibody Product
Table 175. Merck Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 176. Merck Recent Development
Table 177. GeneTex Company Details
Table 178. GeneTex Business Overview
Table 179. GeneTex IgG2b Antibody Product
Table 180. GeneTex Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 181. GeneTex Recent Development
Table 182. NSJ Bioreagents Company Details
Table 183. NSJ Bioreagents Business Overview
Table 184. NSJ Bioreagents IgG2b Antibody Product
Table 185. NSJ Bioreagents Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 186. NSJ Bioreagents Recent Development
Table 187. Mabtech Company Details
Table 188. Mabtech Business Overview
Table 189. Mabtech IgG2b Antibody Product
Table 190. Mabtech Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 191. Mabtech Recent Development
Table 192. American Research Products Company Details
Table 193. American Research Products Business Overview
Table 194. American Research Products IgG2b Antibody Product
Table 195. American Research Products Revenue in IgG2b Antibody Business (2021-2026) & (US$ Million)
Table 196. American Research Products Recent Development
Table 197. IgG2b Antibody Market Trends
Table 198. IgG2b Antibody Market Drivers
Table 199. IgG2b Antibody Market Challenges
Table 200. IgG2b Antibody Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources


List of Figures
Figure 1. IgG2b Antibody Product Picture
Figure 2. Global IgG2b Antibody Market Share by Type: 2025 vs 2032
Figure 3. Monoclonal Antibody Features
Figure 4. Polyclonal Antibody Features
Figure 5. Global IgG2b Antibody Market Share by Application: 2025 vs 2032
Figure 6. Biotechnology
Figure 7. Medical
Figure 8. University
Figure 9. Others
Figure 10. IgG2b Antibody Report Years Considered
Figure 11. Global IgG2b Antibody Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 12. Global IgG2b Antibody Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global IgG2b Antibody Market Share by Revenue, by Region: 2021 vs 2025
Figure 14. North America IgG2b Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Europe IgG2b Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Asia-Pacific IgG2b Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Latin America IgG2b Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Middle East & Africa IgG2b Antibody Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Global IgG2b Antibody Market Share by Players in 2025
Figure 20. Global Top IgG2b Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG2b Antibody as of 2025)
Figure 21. The Top 10 and 5 Players Market Share by IgG2b Antibody Revenue in 2025
Figure 22. North America IgG2b Antibody Market Share by Type (2021-2026)
Figure 23. North America IgG2b Antibody Market Share by Application (2021-2026)
Figure 24. Europe IgG2b Antibody Market Share by Type (2021-2026)
Figure 25. Europe IgG2b Antibody Market Share by Application (2021-2026)
Figure 26. Asia-Pacific IgG2b Antibody Market Share by Type (2021-2026)
Figure 27. Asia-Pacific IgG2b Antibody Market Share by Application (2021-2026)
Figure 28. Latin America IgG2b Antibody Market Share by Type (2021-2026)
Figure 29. Latin America IgG2b Antibody Market Share by Application (2021-2026)
Figure 30. Middle East & Africa IgG2b Antibody Market Share by Type (2021-2026)
Figure 31. Middle East & Africa IgG2b Antibody Market Share by Application (2021-2026)
Figure 32. Bio-Rad Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 33. MyBioSource Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 34. Novus Biologicals Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 35. BosterBio Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 36. RayBiotech Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 37. Biorbyt Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 38. Bio X Cell Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 39. Abeomics Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 40. Cell Sciences Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 41. SouthernBiotech Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 42. Thermo Fisher Scientific Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 43. Miltenyi Biotec Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 44. R&D Systems Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 45. Wuhan Fine Biotech Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 46. BioLegend Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 47. LI-COR Biosciences Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 48. ichorbio Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 49. Proteintech Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 50. OriGene Technologies Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 51. Aviva Systems Biology Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 52. Antigenix America Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 53. LSBio Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 54. Tonbo Biosciences Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 55. BPS Bioscience Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 56. IBL Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 57. Merck Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 58. GeneTex Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 59. NSJ Bioreagents Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 60. Mabtech Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 61. American Research Products Revenue Growth Rate in IgG2b Antibody Business (2021-2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed